期刊
CANCER CELL
卷 18, 期 4, 页码 316-328出版社
CELL PRESS
DOI: 10.1016/j.ccr.2010.09.006
关键词
-
资金
- American Cancer Society [PF-07-261-01-DDC]
- National Cancer Institute [1 F32 CA130312-01A1]
- NCI Mouse Models of Cancer Consortium
- PHS [R01CA113794]
- Stand Up 2 Cancer
- [R01 CA109467]
Epigenetic alterations have been increasingly implicated in oncogenesis. Analysis of Drosophila mutants suggests that Polycomb and SWI/SNF complexes can serve antagonistic developmental roles. However, the relevance of this relationship to human disease is unclear. Here, we have investigated functional relationships between these epigenetic regulators in oncogenic transformation. Mechanistically, we show that loss of the SNF5 tumor suppressor leads to elevated expression of the Polycomb gene EZH2 and that Polycomb targets are broadly H3K27-trimethylated and repressed in SNF5-deficient fibroblasts and cancers. Further, we show antagonism between SNF5 and EZH2 in the regulation of stem cell-associated programs and that Snf5 loss activates those programs. Finally, using conditional mouse models, we show that inactivation of Ezh2 blocks tumor formation driven by Snf5 loss.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据